Biocon Limited has announced that a meeting of its Board of Directors is scheduled for May 7, 2026, to approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Following the results, the company will host an earnings conference call for analysts and investors on May 8, 2026, to discuss the performance of the company for the fourth quarter of the 2025-26 financial year.
Board Meeting Overview
The Board of Directors of Biocon Limited will convene on Thursday, May 7, 2026. The primary objective of this meeting is to review and approve the company’s audited financial results for both the standalone and consolidated entities for the quarter and the full financial year ending March 31, 2026. Furthermore, the board will consider the recommendation of a dividend, along with other routine corporate matters.
Earnings Conference Call Details
Following the release of the financial results, the management team will host an earnings conference call on Friday, May 8, 2026, at 09:00 hrs IST. The session will be conducted via Zoom to facilitate discussion with analysts and investors regarding the company’s financial performance.
Important Investor Information
In accordance with the internal code of conduct for preventing insider trading, the trading window for Biocon securities has been closed from April 1, 2026, and is set to remain closed until May 9, 2026, inclusive. Trading is scheduled to resume on May 10, 2026. Participants interested in joining the conference call are advised to register online and join the session 10 minutes prior to the scheduled start time.
Recording and Transcripts
Post-event documentation will be made accessible through the official company website under the Investor Relations section. The audio recording will be available within 24 hours of the call, followed by the video recording within 48 hours. The official written transcript is expected to be published on the company website within five working days of the call’s conclusion.
Source: BSE
